---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-004933"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2024-04-10T23:59:59+00:00"
generated_at: "2026-06-04T00:19:47.950711+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences gets Nasdaq bid-price extension until Oct 7, 2024; may reverse split

## Summary
- Received Nasdaq Staff notice on April 9, 2024, that minimum $1.00 bid price still not met.
- Granted additional 180-day compliance period; deadline now October 7, 2024.
- If closing bid price ≥ $1.00 for 10 consecutive business days, compliance confirmed.
- Failure by Oct 6, 2024 triggers delisting notice; company may appeal to Hearings Panel.
- Stockholders approved reverse stock split ratio between 1:10 and 1:60 to remedy deficiency.

## SEC filing metadata
- accession: 0001558370-24-004933
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2024-04-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000155837024004933/0001558370-24-004933-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000155837024004933/rsls-20240409x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-004933
- JSON: https://secwatch.observer/filing/0001558370-24-004933.json
- Plain text: https://secwatch.observer/filing/0001558370-24-004933.txt

## Key facts
- Listing & Compliance Notices
  Vyome Holdings, Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: April 9, 2024, the Company received a written notice from the Nasdaq Staff that the Company has not regained compliance with the minimum $1.00 bid price requirement. However, the Nasdaq Staff has determined that the Company is eligible for an additional 180 calendar period, or until October 7, 2024, to regain compliance. If at any time during this period the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days, the Nasdaq Staff will provide the Company with a written confirmation of compliance and the matter will be closed. I
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000155837024004933/0001558370-24-004933-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.